Synap Biotech
PrivateLast Round
Seed
Jun 1, 2026
Total Funding Raised
$115,000
Company Overview
Synap Biotech is a biotechnology company developing intranasal nanobody therapies designed to promote neurological recovery following brain injuries such as strokes and traumatic brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synap Biotech Comparables
Compare Synap Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NovaGo Therapeutics | 78% | |
| Sinntaxis AB | 77% | |
| Oragenics, Inc. | 77% |
Synap Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2026 |
Key People
Founding team and executive leadership
Synap Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Virginia Innovation Partnership Corporation | Seed |
| Center for Entrepreneurial Development | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 88% MoM.
- Jan 20, 2026
Monthly visitors increased 655% MoM.
Synap Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synap Biotech's valuation, stock price, and market status.
Is Synap Biotech a public or private company?
Synap Biotech is a private company.
What is the current stock price of Synap Biotech?
Synap Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Synap Biotech worth (valuation)?
Valuation information for Synap Biotech is not publicly available.
Can I buy Synap Biotech stock?
Synap Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synap Biotech's last funding round?
Synap Biotech's most recent funding round was Seed on June 1, 2026.
Who are the main investors in Synap Biotech?
Key investors in Synap Biotech include Virginia Innovation Partnership Corporation, Center for Entrepreneurial Development.
Will Synap Biotech IPO soon?
No public IPO plans have been announced for Synap Biotech.
How can I track Synap Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synap Biotech's secondary market activity and sign up for updates.